[ascct] Webinar: HCS for Predictive Toxicology using 3D Microtissues

  • From: Kristie Sullivan <KSullivan@xxxxxxxx>
  • To: "ascct@xxxxxxxxxxxxx" <ascct@xxxxxxxxxxxxx>
  • Date: Fri, 1 Sep 2017 03:52:50 +0000

Some of you may be interested in this upcoming webinar.




[Webinar: HCS for Predictive Toxicology and in vitro Pathology Using Simple 3D 
Microtissues]

Webinar: HCS for Predictive Toxicology and in vitro Pathology Using Simple 3D 
Microtissues

Wednesday, 6 September 2017
8am PDT / 11am EDT / 4pm BST / 5pm CEST

[Register 
Now]<http://app.info.perkinelmer.com/e/er?utm_campaign=LST-Toxicology-GLO-2017-Q3-Email-EPKI-Webinar&utm_medium=email&utm_source=Eloqua&s=1674556495&lid=6663&elqTrackId=383e24c473c94b22b12c7ba333712b78&elq=bacadb973f8d4d4a9c27fc013c45f358&elqaid=4969&elqat=1>

This webinar will describe the integration of biology and engineering to devise 
simple, high-throughput 3D human microtissues as predictive biology platforms 
that reflect human physiology and disease, solving fundamental questions of 
adverse biological response with the goal of modernizing toxicity and drug 
candidate testing.

A key aspect of this approach is the implementation of "in vitro pathology", 
making use of quantitative metrics from reconstructed 3D microtissue images to 
discern adverse biological effects. This strategy is currently being used to 
develop 3D microtissues of a variety of human tissues, exploring the utility of 
single cell lines, co-cultures of cells, and human induced pluripotent stem 
cells. The goal is to access a wide variety of cellular behavior, 
characterizing responses across the biological landscape using simple and rapid 
techniques.

Learning outcomes
·         The tension between assay simplicity and biological complexity in 
designing 3D microtissues
·         Development of a human breast cancer MCF-7 3D microtissue model as an 
initial example of the approach
·         The definition of in vitro pathology and its application in 
quantifying the effects of estrogenic exposures in the MCF-7 3D microtissue 
model
·         Challenges and opportunities that arise with primary cells, 
co-cultures, and induced pluripotent stem cells


Speakers


[Kim Boekelheide]

Kim Boekelheide, M.D., Ph.D.
Professor of Pathology and Laboratory Medicine, Brown University School of 
Medicine



[Joe Trask]

Joe Trask
Senior Field Applications Scientist, PerkinElmer









Follow:

[FaceBook]<https://urldefense.proofpoint.com/v2/url?u=http-3A__www.facebook.com_PerkinElmer-3Futm-5Fcampaign-3DLST-2DToxicology-2DGLO-2D2017-2DQ3-2DEmail-2DEPKI-2DWebinar-26utm-5Fmedium-3Demail-26utm-5Fsource-3DEloqua-26sk-3Dwall-26elqTrackId-3Df4d4fc609dcc4c1f88b0f90788c0f37c-26elq-3Dbacadb973f8d4d4a9c27fc013c45f358-26elqaid-3D4969-26elqat-3D1-26elqCampaignId-3D&d=DwMGaQ&c=3mGIBQKb1eS1YDHb7ax3kFkT2UAGBJ12p2lcECIjhXk&r=fG8znKk7OLz0gK_GOP48TMD_8w7rOVYbjDpPMeUT0-k&m=a55Eiu54s7TLLH8HWR5B98ft6fFkesv16MV4FG8-28c&s=SZFr_Ja2HrLTqbhADJgOH4Xw3ga1a0yMmiFbmPB8R0w&e=>

[Twitter]<https://urldefense.proofpoint.com/v2/url?u=https-3A__twitter.com_PKILifeScience-3Futm-5Fcampaign-3DLST-2DToxicology-2DGLO-2D2017-2DQ3-2DEmail-2DEPKI-2DWebinar-26utm-5Fmedium-3Demail-26utm-5Fsource-3DEloqua-26elqTrackId-3Dd0576abefebe4f16992cd98e501013b1-26elq-3Dbacadb973f8d4d4a9c27fc013c45f358-26elqaid-3D4969-26elqat-3D1-26elqCampaignId-3D&d=DwMGaQ&c=3mGIBQKb1eS1YDHb7ax3kFkT2UAGBJ12p2lcECIjhXk&r=fG8znKk7OLz0gK_GOP48TMD_8w7rOVYbjDpPMeUT0-k&m=a55Eiu54s7TLLH8HWR5B98ft6fFkesv16MV4FG8-28c&s=wEgPFjSK892KyDJpXPsZpyRCWOM2esfromk3Kz_Wgtk&e=>

[LinkedIn]<https://urldefense.proofpoint.com/v2/url?u=https-3A__www.linkedin.com_company_life-2Dsciences-2D-26-2Dtechnology-3Futm-5Fcampaign-3DLST-2DToxicology-2DGLO-2D2017-2DQ3-2DEmail-2DEPKI-2DWebinar-26utm-5Fmedium-3Demail-26utm-5Fsource-3DEloqua-26elqTrackId-3D981e647a79174d898a49b71ef935b655-26elq-3Dbacadb973f8d4d4a9c27fc013c45f358-26elqaid-3D4969-26elqat-3D1-26elqCampaignId-3D&d=DwMGaQ&c=3mGIBQKb1eS1YDHb7ax3kFkT2UAGBJ12p2lcECIjhXk&r=fG8znKk7OLz0gK_GOP48TMD_8w7rOVYbjDpPMeUT0-k&m=a55Eiu54s7TLLH8HWR5B98ft6fFkesv16MV4FG8-28c&s=hyMEPT885NymHN8_1Rl0VQbaIPJRxfnWwWZg3mur7kk&e=>

[Google 
Plus]<https://urldefense.proofpoint.com/v2/url?u=https-3A__plus.google.com_-2Bperkinelmer-3Futm-5Fcampaign-3DLST-2DToxicology-2DGLO-2D2017-2DQ3-2DEmail-2DEPKI-2DWebinar-26utm-5Fmedium-3Demail-26utm-5Fsource-3DEloqua-26elqTrackId-3D094ea6465cab4978bc80bfcfef8f9da8-26elq-3Dbacadb973f8d4d4a9c27fc013c45f358-26elqaid-3D4969-26elqat-3D1-26elqCampaignId-3D&d=DwMGaQ&c=3mGIBQKb1eS1YDHb7ax3kFkT2UAGBJ12p2lcECIjhXk&r=fG8znKk7OLz0gK_GOP48TMD_8w7rOVYbjDpPMeUT0-k&m=a55Eiu54s7TLLH8HWR5B98ft6fFkesv16MV4FG8-28c&s=yshHRz3-LOx5xM9cVSqug-7ctt7umyO9eD1CuRUMs5M&e=>

[YouTube]<https://urldefense.proofpoint.com/v2/url?u=http-3A__www.youtube.com_perkinelmer-3Futm-5Fcampaign-3DLST-2DToxicology-2DGLO-2D2017-2DQ3-2DEmail-2DEPKI-2DWebinar-26utm-5Fmedium-3Demail-26utm-5Fsource-3DEloqua-26elqTrackId-3D3cd1d9c9b3ee43b89927d4f91480b6bb-26elq-3Dbacadb973f8d4d4a9c27fc013c45f358-26elqaid-3D4969-26elqat-3D1-26elqCampaignId-3D&d=DwMGaQ&c=3mGIBQKb1eS1YDHb7ax3kFkT2UAGBJ12p2lcECIjhXk&r=fG8znKk7OLz0gK_GOP48TMD_8w7rOVYbjDpPMeUT0-k&m=a55Eiu54s7TLLH8HWR5B98ft6fFkesv16MV4FG8-28c&s=x1l6cMzi-HB55TTgHBwgQh3TrAp4YVXIUxXbDwar0EI&e=>



Manage Your PerkinElmer Preferences or 
Unsubscribe<http://info.perkinelmer.com/preferences?utm_campaign=LST-Toxicology-GLO-2017-Q3-Email-EPKI-Webinar&utm_medium=email&utm_source=Eloqua&c=&elqTrackId=cc24b9e4c60f4882902ddcfbea12f332&elq=bacadb973f8d4d4a9c27fc013c45f358&elqaid=4969&elqat=1&elqCampaignId=>
 | Privacy 
Policy<http://www.perkinelmer.com/corporate/policies/privacy-policy.html?utm_campaign=LST-Toxicology-GLO-2017-Q3-Email-EPKI-Webinar&utm_medium=email&utm_source=Eloqua&elqTrackId=95356572249a47ea9c7076dbc6e47481&elq=bacadb973f8d4d4a9c27fc013c45f358&elqaid=4969&elqat=1&elqCampaignId=>
 | Contact 
Us<http://www.perkinelmer.com/corporate/contactus?utm_campaign=LST-Toxicology-GLO-2017-Q3-Email-EPKI-Webinar&utm_medium=email&utm_source=Eloqua&elqTrackId=06d2088691324bb5b620007bb57faeb8&elq=bacadb973f8d4d4a9c27fc013c45f358&elqaid=4969&elqat=1&elqCampaignId=>


©2017 PerkinElmer, Inc. All rights reserved.
PerkinElmer, Inc. | 940 Winter Street | Waltham, MA 02451 USA | 
www.perkinelmer.com<http://www.perkinelmer.com?utm_campaign=LST-Toxicology-GLO-2017-Q3-Email-EPKI-Webinar&utm_medium=email&utm_source=Eloqua&elqTrackId=4949f1db89434708b4b918245938bcde&elq=bacadb973f8d4d4a9c27fc013c45f358&elqaid=4969&elqat=1&elqCampaignId=>

[http://app.info.perkinelmer.com/e/FooterImages/FooterImage1?elq=bacadb973f8d4d4a9c27fc013c45f358&siteid=1674556495]

Other related posts:

  • » [ascct] Webinar: HCS for Predictive Toxicology using 3D Microtissues - Kristie Sullivan